Literature DB >> 22248302

From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.

A M S Murugaiah1, Xiongyu Wu, Charlotta Wallinder, A K Mahalingam, Yiqian Wan, Christian Sköld, Milad Botros, Marie-Odile Guimond, Advait Joshi, Fred Nyberg, Nicole Gallo-Payet, Anders Hallberg, Mathias Alterman.   

Abstract

A para substitution pattern of the phenyl ring is a characteristic feature of the first reported selective AT(2) receptor agonist M024/C21 (1) and all the nonpeptidic AT(2) receptor agonists described so far. Two series of compounds structurally related to 1 but with a meta substitution pattern have now been synthesized and biologically evaluated for their affinity to the AT(1) and AT(2) receptors. A high AT(2)/AT(1) receptor selectivity was obtained with all 41 compounds synthesized, and the majority exhibited K(i) ranging from 2 to 100 nM. Five compounds were evaluated for their functional activity at the AT(2) receptor, applying a neurite outgrowth assay in NG108-15 cells. Notably, four of the five compounds, with representatives from both series, acted as potent AT(2) receptor antagonists. These compounds were found to be considerably more effective than PD 123,319, the standard AT(2) receptor antagonist used in most laboratories. No AT(2) receptor antagonists were previously reported among the derivatives with a para substitution pattern. Hence, by a minor modification of the agonist 1 it could be transformed into the antagonist, compound 38. These compounds should serve as valuable tools in the assessment of the role of the AT(2) receptor in more complex physiological models.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22248302     DOI: 10.1021/jm2015099

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Saralasin and Sarile Are AT2 Receptor Agonists.

Authors:  Marie-Odile Guimond; Mathias Hallberg; Nicole Gallo-Payet; Charlotta Wallinder
Journal:  ACS Med Chem Lett       Date:  2014-08-18       Impact factor: 4.345

2.  Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.

Authors:  Charlotta Wallinder; Christian Sköld; Milad Botros; Marie-Odile Guimond; Mathias Hallberg; Nicole Gallo-Payet; Anders Karlén; Mathias Alterman
Journal:  ACS Med Chem Lett       Date:  2014-12-08       Impact factor: 4.345

Review 3.  AT2 receptor activities and pathophysiological implications.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2015-03       Impact factor: 3.105

Review 4.  Update on the angiotensin AT(2) receptor.

Authors:  Claudia A McCarthy; Robert E Widdop; Kate M Denton; Emma S Jones
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 5.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

6.  Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells.

Authors:  Mario Menk; Jan Adriaan Graw; Clarissa von Haefen; Marco Sifringer; David Schwaiberger; Thomas Unger; Ulrike Steckelings; Claudia D Spies
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

7.  Postprandial fatty acid uptake and adipocyte remodeling in angiotensin type 2 receptor-deficient mice fed a high-fat/high-fructose diet.

Authors:  Christophe Noll; Sébastien M Labbé; Sandra Pinard; Michael Shum; Lyne Bilodeau; Lucie Chouinard; Serge Phoenix; Roger Lecomte; André C Carpentier; Nicole Gallo-Payet
Journal:  Adipocyte       Date:  2015-12-08       Impact factor: 4.534

8.  Structural basis for selectivity and diversity in angiotensin II receptors.

Authors:  Haitao Zhang; Gye Won Han; Alexander Batyuk; Andrii Ishchenko; Kate L White; Nilkanth Patel; Anastasiia Sadybekov; Beata Zamlynny; Michael T Rudd; Kaspar Hollenstein; Alexandra Tolstikova; Thomas A White; Mark S Hunter; Uwe Weierstall; Wei Liu; Kerim Babaoglu; Eric L Moore; Ryan D Katz; Jennifer M Shipman; Margarita Garcia-Calvo; Sujata Sharma; Payal Sheth; Stephen M Soisson; Raymond C Stevens; Vsevolod Katritch; Vadim Cherezov
Journal:  Nature       Date:  2017-04-05       Impact factor: 49.962

9.  A Series of Analogues to the AT2R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode.

Authors:  Rebecka Isaksson; Jens Lindman; Johan Wannberg; Jessica Sallander; Maria Backlund; Dhaniel Baraldi; Robert Widdop; Mathias Hallberg; Johan Åqvist; Hugo Gutierrez de Teran; Johan Gising; Mats Larhed
Journal:  ChemistryOpen       Date:  2019-01-24       Impact factor: 2.911

10.  The Angiotensin II Type 2 Receptor in Brain Functions: An Update.

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Int J Hypertens       Date:  2012-12-25       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.